Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Combination Therapy for Hypertension Management

Patient Selection and Monitoring

  • The American Heart Association recommends monitoring blood pressure, heart rate, and ECG when initiating combination therapy with bisoprolol and cilnidipine, particularly in patients with pre-existing bradycardia or conduction abnormalities, such as those with first-degree AV block, bradycardia, hypotension, or heart failure 2
  • The American College of Cardiology suggests that bisoprolol can be safely used in patients with chronic obstructive pulmonary disease due to its high beta-1 selectivity, but should still be used with caution 1

Special Populations

  • The American Heart Association recommends that for patients with heart failure, bisoprolol is one of the three beta-blockers proven to reduce mortality, but careful titration is required 3, 4
  • The European Society of Cardiology suggests that in patients with peripheral artery disease, beta-blockers like bisoprolol should be used with caution as they may exacerbate symptoms 1
  • The American Diabetes Association recommends that for patients with diabetes, newer vasodilating beta-blockers may be preferred, though bisoprolol can still be used with appropriate monitoring 5